A detailed history of Wolverine Trading, LLC transactions in Arvinas, Inc. stock. As of the latest transaction made, Wolverine Trading, LLC holds 37,200 shares of ARVN stock, worth $687,456. This represents 0.0% of its overall portfolio holdings.

Number of Shares
37,200
Previous 19,800 87.88%
Holding current value
$687,456
Previous $527,000 73.81%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$36.38 - $52.31 $90,295 - $129,833
2,482 Added 25.36%
12,269 $506,000
Q4 2023

Feb 14, 2024

BUY
$14.19 - $42.33 $138,877 - $414,283
9,787 New
9,787 $402,000

Others Institutions Holding ARVN

About ARVINAS, INC.


  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $983M
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.